Table III.
Parameters associated with glucose and lipid metabolism (n=10).
Group | BG (mmol/l) | TAG (mmol/l) | TC (mmol/l) | HDLC (mmol/l) | LDLC (mmol/l) |
---|---|---|---|---|---|
Control | |||||
0 weeks | 4.78±0.27 | 1.05±0.39 | 2.71±0.12 | 1.00±0.14 | 0.64±0.06 |
4 weeks | 4.75±0.34 | 1.03±0.44 | 2.73±0.13 | 1.03±0.13 | 0.65±0.11 |
8 weeks | 4.81±0.33 | 0.97±0.52 | 2.75±0.09 | 1.06±0.11 | 0.66±0.09 |
TAG | |||||
0 weeks | 20.18±1.14a | 2.93±0.19a | 3.54±0.28a | 0.71±0.09a | 1.11±0.15a |
4 weeks | 20.95±1.78a | 2.99±0.18a | 3.64±0.26a | 0.66±0.07a | 1.14±0.16a |
8 weeks | 20.97±2.61a | 3.10±0.22a | 3.68±0.24a | 0.66±0.09a | 1.18±0.16a |
Low-DAG | |||||
0 weeks | 20.23±1.39a | 3.08±0.14a | 3.53±0.28a | 0.77±0.08a | 1.11±0.15a |
4 weeks | 19.93±1.25a | 3.03±0.13a | 3.45±0.19a,b | 0.82±0.09a,b | 1.10±0.12a |
8 weeks | 19.77±0.92a | 2.89±0.20a | 3.34±0.20a,b | 0.83±0.08a,b | 1.06±0.20a |
High-DAG | |||||
0 weeks | 20.73±2.04a | 3.04±0.21a | 3.55±0.31a | 0.73±0.08a | 1.11±0.15a |
4 weeks | 19.29±1.71a–c | 2.85±0.20a | 3.35±0.19a,b | 0.76±0.08a,b | 1.05±0.16a |
8 weeks | 18.36±0.81a–c | 2.45±0.29a–c | 3.21±0.15a–c | 0.79±0.11a,b | 1.08±0.19a |
P-value | |||||
Time | <0.0001 | <0.0001 | 0.32 | 0.05 | 0.81 |
Oil | <0.0001 | <0.0001 | 0.48 | <0.0001 | <0.0001 |
Time × oil | <0.0001 | <0.0001 | 0.41 | 0.026 | 0.023 |
P<0.05 vs. control group
P<0.05 vs. TAG group.
P<0.05 vs. 0 weeks in each group. Quantitative data are expressed as the mean ± standard deviation (n=10). Analysis of variance was used to analyze the difference between weeks 0 and 8, while multiple comparison between the groups was performed using the least significant difference t-test method. TAG, triacylglycerol; DAG, diacylglycerol; BG, blood glucose; TC, total cholesterol; HDLC, high-density lipoprotein cholesterol; LDLC, low-density lipoprotein cholesterol.